-
Steris (STE) Declares $0.63 Quarterly Dividend; 1% Yield
-
KeyBanc on Medical Technology: 'From Reset to Rebound?'
-
Needham Reiterates Hold Rating on STERIS (STE)
-
Steris (STE) Tops Q3 EPS by 11c, provides guidance
-
Steris (STE) Declares $0.63 Quarterly Dividend; 1.1% Yield
-
Steris (STE) Tops Q2 EPS by 8c
-
Piper Sandler lists 5 MedTech stock ideas for H2 2025
-
Morgan Stanley Upgrades STERIS (STE) to Overweight
-
STERIS Corp. (STE) wins $450 million DoD contract extension for medical gear
-
Jefferies Starts STERIS (STE) at Hold
-
STERIS (STE) PT Raised to $280 at Citizens JMP
-
Citizens JMP Reiterates Market Outperform Rating on STERIS (STE)
-
Steris (STE) Tops Q1 EPS by 14c ; Offers Guidance
-
Citizens JMP Reiterates Market Outperform Rating on STERIS (STE)
-
Steris (STE) Misses Q4 EPS by 1c
-
STERIS (STE) PT Raised to $265 at Piper Sandler Following a 'Solid' Quarter
-
Steris (STE) Announces Outcome of Ethylene Oxide Trial
-
Steris (STE) Tops Q3 EPS by 1c, reiterates outlook
-
Steris (STE) Declares $0.57 Quarterly Dividend; 1% Yield
-
Piper Sandler Upgrades STERIS (STE) to Overweight
-
STERIS (STE) PT Raised to $265 at KeyBanc
-
Steris (STE) Tops Q2 EPS by 5c; reaffirms FY25 outlook
-
Piper Sandler Reiterates Neutral Rating on STERIS (STE)
-
6 MedTech stocks to own - KeyBanc

